Search results
FDA Grants Withdrawal of Infigratinib for Cholangiocarcinoma
Medscape· 21 hours agoThe US Food and Drug Administration (FDA) has announced the withdrawal of its 2021 accelerated approval of infigratinib (Truseltiq) for patients with a certain type of previously ...
FDA Greenlights Elon Musk’s Neuralink to Take Major Step Forward
The Daily Beast· 1 day agoThe U.S. Food and Drug Administration has cleared Elon Musk’s company Neuralink to implant a second...
Roche's Inavolisib Breast Cancer Treatment Gets FDA Breakthrough Therapy Designation
Market Watch· 21 hours agoBy Pierre Bertrand Roche said that the U.S. Food and Drug Administration has designated its Inavolisib breast cancer treatment as a breakthrough therapy. A...
Biocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
Investing.com· 21 hours agoBiocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
Trump says he is open to restrictions on contraception before backing away from the statement
San Francisco Chronicle· 1 hour agoFormer President Donald Trump on Tuesday said he was open to supporting regulations on contraception...
FDA said it never inspected dental lab that made controversial AGGA device
Medical Xpress· 6 days agoThe FDA never inspected Johns Dental Laboratories during more than a decade in which it made the...
FDA greenlights self-collection of vaginal samples for cervical cancer screening
WYFF 4 Greenville· 5 days agoTwo health care businesses – biotechnology company Roche and medical technology firm Becton, Dickson...
FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
Zacks via Yahoo Finance· 6 days agoPer the FDA, the data submitted by Ascendis (ASND) for its hormone replacement therapy constitutes a...
FDA considers ban on device that delivers shocks to people with disabilities
WCVB Boston· 1 day agoThe U.S. Food and Drug Administration is accepting comments until next week before deciding whether...
Elon Musk’s Neuralink Gets FDA Green Light for Second Patient, as First Describes His Emotional...
The Wall Street Journal· 2 days agoWith the FDA’s blessing, Neuralink now hopes to implant a second participant sometime in June,...